What is the optimal therapeutic option for patients diagnosed with hormone receptor-positive, HER2-negative breast cancer in visceral crisis?—insights from the RIGHT CHOICE trial
@article{ACTR10221, author = {Alexandre Xu-Vuillard and Thomas Grinda}, title = {What is the optimal therapeutic option for patients diagnosed with hormone receptor-positive, HER2-negative breast cancer in visceral crisis?—insights from the RIGHT CHOICE trial}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10221} }